Meei-yun Lin
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
Journal: PloS one
Published: March 28, 2022
Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine.
Journal: Scientific reports
Published: March 03, 2022
Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P.
Journal: The Journal of infectious diseases
Published: January 21, 2022
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2.
Journal: Theranostics
Published: July 31, 2021
Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 29, 2021
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.
Journal: Scientific reports
Published: January 15, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026